Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Chemed Corporation    CHE

CHEMED CORPORATION

(CHE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/26/2020 10/27/2020 10/28/2020 10/29/2020 10/30/2020 Date
492.41(c) 484.26(c) 472.66(c) 473.53(c) 478.32(c) Last
50 902 47 886 50 285 93 229 115 392 Volume
+0.77% -1.66% -2.40% +0.18% +1.01% Change
More quotes
Financials (USD)
Sales 2020 2 079 M - -
Net income 2020 287 M - -
Net Debt 2020 - - -
P/E ratio 2020 27,4x
Yield 2020 0,28%
Sales 2021 2 260 M - -
Net income 2021 279 M - -
Net Debt 2021 - - -
P/E ratio 2021 28,5x
Yield 2021 0,28%
Capitalization 7 538 M 7 538 M -
Capi. / Sales 2020 3,63x
Capi. / Sales 2021 3,34x
Nbr of Employees 16 641
Free-Float 43,0%
More Financials
Company
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is... 
Sector
Healthcare Facilities & Services
Calendar
10/30 | 10:00amEarnings Call
More about the company
Notations Surperformance© of Chemed Corporation
Trading Rating : Investor Rating :
More Ratings
All news about CHEMED CORPORATION
09:30aCHEMED : 2020 Q3 Investor Presentation
PU
10/29CHEMED : 3Q Earnings Snapshot
AQ
10/29CHEMED CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
10/29CHEMED : Reports Third-Quarter 2020 Results
BU
10/12CHEMED : To Report Third-Quarter 2020 Earnings October 29, Related Conference Ca..
BU
09/17CHEMED : Robert Goldschmidt Named President of Roto-Rooter
PR
09/01CHEMED CORP : Change in Directors or Principal Officers (form 8-K)
AQ
08/14CHEMED CORPORATION : Ex-dividend day for
FA
08/06CHEMED CORPORATION : Declares Quarterly Dividend of 34 Cents
BU
07/31CHEMED : Management's Discussion and Analysis of Financial Condition and Results..
AQ
07/30CHEMED CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
07/29CHEMED : 2Q Earnings Snapshot
AQ
07/29CHEMED : Reports Second-Quarter 2020 Results
BU
07/08CHEMED : To Report Second-Quarter 2020 Earnings July 29, Related Conference Call..
BU
05/27CHEMED CORPORATION : to Present at the Jefferies 2020 Virtual Healthcare Confere..
BU
More news
News in other languages on CHEMED CORPORATION
02/13CHEMED CORPORATION : Veröffentlichung des Jahresergebnisses
02/13CHEMED CORPORATION : publication des résultats annuels
2016CHEMED CORPORATION : Veröffentlichung des Halbjahresergebnisses
2016CHEMED CORPORATION : publication des résultats semestriels
2016CHEMED CORPORATION : Veröffentlichung des Quartalsergebnisses
More news
Chart CHEMED CORPORATION
Duration : Period :
Chemed Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHEMED CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 553,00 $
Last Close Price 478,32 $
Spread / Highest target 25,4%
Spread / Average Target 15,6%
Spread / Lowest Target 8,09%
EPS Revisions
Managers
NameTitle
Kevin J. McNamara President, Chief Executive Officer & Director
George J. Walsh Chairman
David Patrick Williams Chief Financial Officer & Executive Vice President
Joel F. Gemunder Independent Director
Thomas C. Hutton Director & Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CHEMED CORPORATION8.89%7 538
CVS HEALTH CORPORATION-24.71%73 196
HCA HEALTHCARE, INC.-15.16%42 389
FRESENIUS MEDICAL CARE AG & CO. KGAA0.36%22 604
LABORATORY CORPORATION OF AMERICA HOLDINGS17.94%19 433
QUEST DIAGNOSTICS15.15%16 572